植え込み型神経刺激装置市場レポート：動向、予測、競合分析 (2031年まで)

世界の植え込み型神経刺激装置市場の将来は、パーキンソン病、てんかん、疼痛管理市場に機会があり、有望視されています。世界の植え込み型神経刺激装置市場は、2025年から2031年にかけてCAGR 11.8％で成長すると予想されています。この市場の主な促進要因は、神経疾患に対する低侵襲治療に対する需要の高まりと、疼痛管理とリハビリテーションのための神経刺激療法の採用が増加していることです。

• Lucintelの予測では、種類別では胃電気刺激が予測期間中に最も高い成長を遂げる見込みです。
• 用途別では、パーキンソン病が最も高い成長が見込まれます。
• 地域別では、アジア太平洋が予測期間中に最も高い成長が見込まれています。

植え込み型神経刺激装置市場の新たな動向

世界の植え込み型神経刺激装置市場は、技術的進歩、臨床応用の拡大、低侵襲で個別化された治療に対する患者需要の増加により、変革期を迎えています。神経系の特定部位に標的電気刺激を与えるこれらの機器は、ますます洗練され汎用性が高まっています。治療メーカーは、患者の転帰を改善し、治療の選択肢を広げ、神経刺激療法の全体的な効率を高める革新的なソリューションの開発に注力しています。このようなダイナミックな状況が、植え込み型神経刺激の将来を形成しています。

• 小型化とワイヤレス技術：神経刺激装置はより小型で目立たないものとなり、患者の快適性を向上させ、植込み手技の侵襲性を減らしています。ワイヤレス接続により、プログラミング、遠隔モニタリング、データ収集が容易になり、患者の利便性と医師の管理が向上します。この動向の背景には、あまり目立たない機器を好む患者の嗜好と、高度なマイクロエレクトロニクスの利用可能性が高まっていることがあります。小型の装置は低侵襲手術で植え込むことができ、回復時間と合併症のリスクを軽減します。ワイヤレス技術はリアルタイムのデータ伝送を可能にし、医師が遠隔で刺激パラメーターを調整し、治療を最適化することを可能にします。
• 個別化治療と閉ループシステム：個々の患者のニーズに適応し、的を絞った刺激を与えることができる機器により、焦点は個別化治療へとシフトしています。リアルタイムの生理学的フィードバックに基づいて刺激を自動的に調整するクローズド・ループ・システムが人気を集めています。この動向は、神経症状における個人差への理解が深まり、カスタマイズされた治療アプローチの必要性が高まっていることに後押しされています。個別化治療は、治療効果を最大化し副作用を最小化するために、刺激パラメーターを微調整することを可能にします。クローズドループシステムは、患者の活動や症状の変化に基づいて刺激を動的に調整することができ、より効果的で一貫性のある治療を提供することができます。
• 痛みを超えた応用の拡大：研究では、てんかん、パーキンソン病、アルツハイマー病、さらには精神疾患など、慢性疼痛以外の幅広い疾患に対する植え込み型神経刺激の利用が模索されています。このような拡大の背景には、神経系に対する理解の深まりと、さまざまな神経経路を調節する神経刺激の可能性があります。用途の拡大はメーカーに新たな市場機会をもたらし、現在管理が困難な状態の患者に治療の選択肢を提供する可能性があります。このような多様化はイノベーションを促進し、研究開発への投資を引き寄せています。
• デジタルヘルスプラットフォームとの統合：植え込み型神経刺激システムはデジタルヘルスプラットフォームとの統合が進んでおり、遠隔モニタリング、データ収集、患者関与を可能にしています。この統合により、医師は患者の経過を追跡し、動向を把握し、治療計画をより効果的に個別化できるようになります。この動向の背景には、デジタルヘルス技術の導入が進み、患者とヘルスケアプロバイダー間のシームレスなデータ交換が必要になっていることがあります。デジタルヘルスプラットフォームとの統合は、患者が自分のケアにより積極的に参加できるようにし、ヘルスケア専門家の遠隔管理を容易にします。
• 神経調節メカニズムへの注目：神経調節のメカニズムに対する深い理解が、より的を絞った効果的な神経刺激療法の開発を後押ししています。研究者たちは、電気刺激が神経回路にどのような影響を及ぼすか、また望ましい治療効果を得るために刺激パラメータを最適化する方法を調査しています。このような神経調節メカニズムへの注目は、より洗練された刺激プロトコルと装置設計の開発につながっています。神経刺激の仕組みがよりよく理解されれば、より精密で効果的な治療法の開発が可能になります。

このような新たな動向は、技術革新を促進し、治療の選択肢を拡大し、患者の転帰を改善することで、世界の植え込み型神経刺激装置市場を再構築しています。市場は、より個別化され、侵襲性が低く、より統合されたソリューションへと向かっており、最終的には神経疾患患者の生活の質の向上につながります。

植え込み型神経刺激装置市場の最近の動向

世界の植え込み型神経刺激装置市場は、技術革新、臨床応用の拡大、低侵襲で個別化された治療に対する患者の需要の増加などを背景に、急速な発展を遂げています。これらのデバイスは、慢性疼痛、パーキンソン病、てんかん、運動障害など、さまざまな神経疾患の標的治療を提供します。最近の動向は、デバイス技術の向上、アプリケーションの拡大、デジタルヘルスプラットフォームとの統合の強化に重点が置かれています。メーカー各社は、有効性の向上、治療選択肢の拡大、患者の転帰改善のための研究開発に投資しています。

• 先進デバイス技術：マイクロエレクトロニクス、バッテリー技術、生体材料の進歩により、植え込み型神経刺激装置の小型化、高性能化、長寿命化が進んでいます。これには、より正確な刺激のための電極設計の改善、無線通信機能の強化、完全植え込み式で充電可能なシステムの開発などが含まれます。これらの技術的進歩により、より的を絞った効率的な刺激が可能になり、治療効果が向上し、副作用が減少する可能性があります。より小型の装置は、より低侵襲な手技で植え込むことができるため、回復までの時間が短縮され、合併症のリスクも低減されます。
• 臨床応用の拡大：アルツハイマー病、うつ病、外傷性脳損傷、さらには自己免疫疾患など、従来の疼痛管理にとどまらず、より広範な疾患に対する植え込み型神経刺激の使用が調査されています。このような拡大の背景には、神経系に対する理解の深まりと、さまざまな疾患に関与する神経経路を調節する神経刺激の可能性があります。用途の拡大は新たな市場機会を開拓し、現在管理が困難な状態の患者に対する治療ソリューションの可能性を提供します。このような多様化は、この分野のさらなる研究開発の原動力となります。
• 個別化治療と適応刺激：個別化医療の動向は、個々の患者のニーズに合わせた神経刺激システムの開発に影響を与えています。これには、リアルタイムの生理学的フィードバックに基づいて刺激パラメーターを調整する適応刺激アルゴリズムや、遠隔モニタリングおよびプログラミング機能などの機能が含まれます。個別化治療は、症状や刺激に対する反応の個人差を考慮することで、治療結果を最適化することを目的としています。このアプローチは、より効果的な治療と副作用の最小化につながります。
• デジタルヘルスプラットフォームとの統合：植え込み型神経刺激システムは、デジタルヘルスプラットフォームとの統合が進んでおり、患者の遠隔モニタリング、データ収集、遠隔医療相談を可能にしています。この統合により、医師は患者の経過を追跡し、動向を把握し、治療計画を遠隔で調整することができます。デジタルヘルスプラットフォームを統合することで、患者のエンゲージメントを向上させ、患者がより積極的にケアに参加できるようになります。また、ヘルスケア専門家の遠隔管理も容易になり、特に遠隔地の患者のケアへのアクセスが向上します。
• クローズドループシステムへの注力：リアルタイムの生理学的フィードバックに基づいて刺激パラメーターを自動的に調整するクローズドループ神経刺激システムが人気を集めています。これらのシステムは、患者の活動や症状の変化に基づいて刺激を動的に調整することができ、より効果的で一貫性のある治療を提供することができます。クローズドループシステムは、必要なときだけ刺激を与え、個々の患者のニーズにリアルタイムで適応することで、治療成績を大幅に改善する可能性を秘めています。この技術は、個別化された神経刺激における重要な進歩です。

このような開発は、世界の植え込み型神経刺激装置市場を変革し、より高度で個別化された、利用しやすい治療につながります。同市場は、侵襲性の低い手技、アプリケーションの拡大、デジタルヘルスプラットフォームとの統合の拡大へと向かっており、最終的には患者の転帰と生活の質の向上につながります。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

• 背景と分類
• サプライチェーン

第3章 市場動向と予測分析

• マクロ経済の動向と予測
• 業界の促進要因と課題
• PESTLE分析
• 特許分析
• 規制環境

第4章 世界の植え込み型神経刺激装置市場：種類別

• 概要
• 魅力分析：種類別
• 脊髄刺激療法（SCS）：動向と予測（2019～2031年）
• 胃電気刺激（GES）：動向と予測（2019～2031年）
• 脳深部刺激療法（DBS）：動向と予測（2019～2031年）
• 仙骨神経刺激（SNS）：動向と予測（2019～2031年）
• 迷走神経刺激（VNS）：動向と予測（2019～2031年）
• その他：動向と予測（2019～2031年）

第5章 世界の植え込み型神経刺激装置市場：用途別

• 概要
• 魅力分析：用途別
• パーキンソン病：動向と予測（2019～2031年）
• てんかん：動向と予測（2019～2031年）
• 疼痛管理：動向と予測（2019～2031年）
• その他：動向と予測（2019～2031年）

第6章 地域分析

• 概要
• 植え込み型神経刺激装置市場：地域別

第7章 北米の植え込み型神経刺激装置市場

• 概要
• 北米の植え込み型神経刺激装置市場：種類別
• 北米の植え込み型神経刺激装置市場：用途別
• 米国の植え込み型神経刺激装置市場
• メキシコの植え込み型神経刺激装置市場
• カナダの植え込み型神経刺激装置市場

第8章 欧州の植え込み型神経刺激装置市場

• 概要
• 欧州の植え込み型神経刺激装置市場：種類別
• 欧州の植え込み型神経刺激装置市場：用途別
• ドイツの植え込み型神経刺激装置市場
• フランスの植え込み型神経刺激装置市場
• スペインの植え込み型神経刺激装置市場
• イタリアの植え込み型神経刺激装置市場
• 英国の植え込み型神経刺激装置市場

第9章 アジア太平洋の植え込み型神経刺激装置市場

• 概要
• アジア太平洋の植え込み型神経刺激装置市場：種類別
• アジア太平洋の植え込み型神経刺激装置市場：用途別
• 日本の植え込み型神経刺激装置市場
• インドの植え込み型神経刺激装置市場
• 中国の植え込み型神経刺激装置市場
• 韓国の植え込み型神経刺激装置市場
• インドネシアの植え込み型神経刺激装置市場

第10章 その他の地域 (ROW) の植え込み型神経刺激装置市場

• 概要
• その他の地域 (ROW) の植え込み型神経刺激装置市場：種類別
• その他の地域 (ROW) の植え込み型神経刺激装置市場：用途別
• 中東の植え込み型神経刺激装置市場
• 南米の植え込み型神経刺激装置市場
• アフリカの植え込み型神経刺激装置市場

第11章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析
  • 競争企業間の敵対関係
  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
• 市場シェア分析

第12章 機会と戦略分析

• バリューチェーン分析
• 成長機会分析
  • 成長機会：種類別
  • 成長機会：用途別
• 世界の植え込み型神経刺激装置市場の新たな動向
• 戦略分析
  • 新製品開発
  • 認証・ライセンシング
  • 企業合併・買収 (M&A) 、契約、提携、合弁事業

第13章 バリューチェーン上の主要企業のプロファイル

• Competitive Analysis
• Medtronic
• Boston Scientific
• Abbott
• LivaNova
• Nevro
• Ruishenan Medical
• Beijing Pins
• Sceneray
• Inspire Medical Systems
• Nurotron

第14章 付録

• 図の一覧
• 表の一覧
• 分析手法
• 免責事項
• 著作権
• 略語と技術単位
• Lucintelについて
• お問い合わせ

List of Figures

• Figure 1.1: Trends and Forecast for the Global Implantable Neurostimulation Device Market
• Figure 2.1: Usage of Implantable Neurostimulation Device Market
• Figure 2.2: Classification of the Global Implantable Neurostimulation Device Market
• Figure 2.3: Supply Chain of the Global Implantable Neurostimulation Device Market
• Figure 2.4: Driver and Challenges of the Implantable Neurostimulation Device Market
• Figure 3.1: Trends of the Global GDP Growth Rate
• Figure 3.2: Trends of the Global Population Growth Rate
• Figure 3.3: Trends of the Global Inflation Rate
• Figure 3.4: Trends of the Global Unemployment Rate
• Figure 3.5: Trends of the Regional GDP Growth Rate
• Figure 3.6: Trends of the Regional Population Growth Rate
• Figure 3.7: Trends of the Regional Inflation Rate
• Figure 3.8: Trends of the Regional Unemployment Rate
• Figure 3.9: Trends of Regional Per Capita Income
• Figure 3.10: Forecast for the Global GDP Growth Rate
• Figure 3.11: Forecast for the Global Population Growth Rate
• Figure 3.12: Forecast for the Global Inflation Rate
• Figure 3.13: Forecast for the Global Unemployment Rate
• Figure 3.14: Forecast for the Regional GDP Growth Rate
• Figure 3.15: Forecast for the Regional Population Growth Rate
• Figure 3.16: Forecast for the Regional Inflation Rate
• Figure 3.17: Forecast for the Regional Unemployment Rate
• Figure 3.18: Forecast for Regional Per Capita Income
• Figure 4.1: Global Implantable Neurostimulation Device Market by Type in 2019, 2024, and 2031
• Figure 4.2: Trends of the Global Implantable Neurostimulation Device Market ($B) by Type
• Figure 4.3: Forecast for the Global Implantable Neurostimulation Device Market ($B) by Type
• Figure 4.4: Trends and Forecast for Spinal Cord Stimulation (SCS) in the Global Implantable Neurostimulation Device Market (2019-2031)
• Figure 4.5: Trends and Forecast for Gastric Electric Stimulation (GES) in the Global Implantable Neurostimulation Device Market (2019-2031)
• Figure 4.6: Trends and Forecast for Deep Brain Stimulation (DBS) in the Global Implantable Neurostimulation Device Market (2019-2031)
• Figure 4.7: Trends and Forecast for Sacral Nerve Stimulation (SNS) in the Global Implantable Neurostimulation Device Market (2019-2031)
• Figure 4.8: Trends and Forecast for Vagus Nerve Stimulation (VNS) in the Global Implantable Neurostimulation Device Market (2019-2031)
• Figure 4.9: Trends and Forecast for Others in the Global Implantable Neurostimulation Device Market (2019-2031)
• Figure 5.1: Global Implantable Neurostimulation Device Market by Application in 2019, 2024, and 2031
• Figure 5.2: Trends of the Global Implantable Neurostimulation Device Market ($B) by Application
• Figure 5.3: Forecast for the Global Implantable Neurostimulation Device Market ($B) by Application
• Figure 5.4: Trends and Forecast for Parkinson's Disease in the Global Implantable Neurostimulation Device Market (2019-2031)
• Figure 5.5: Trends and Forecast for Epilepsy in the Global Implantable Neurostimulation Device Market (2019-2031)
• Figure 5.6: Trends and Forecast for Pain Management in the Global Implantable Neurostimulation Device Market (2019-2031)
• Figure 5.7: Trends and Forecast for Others in the Global Implantable Neurostimulation Device Market (2019-2031)
• Figure 6.1: Trends of the Global Implantable Neurostimulation Device Market ($B) by Region (2019-2024)
• Figure 6.2: Forecast for the Global Implantable Neurostimulation Device Market ($B) by Region (2025-2031)
• Figure 7.1: Trends and Forecast for the North American Implantable Neurostimulation Device Market (2019-2031)
• Figure 7.2: North American Implantable Neurostimulation Device Market by Type in 2019, 2024, and 2031
• Figure 7.3: Trends of the North American Implantable Neurostimulation Device Market ($B) by Type (2019-2024)
• Figure 7.4: Forecast for the North American Implantable Neurostimulation Device Market ($B) by Type (2025-2031)
• Figure 7.5: North American Implantable Neurostimulation Device Market by Application in 2019, 2024, and 2031
• Figure 7.6: Trends of the North American Implantable Neurostimulation Device Market ($B) by Application (2019-2024)
• Figure 7.7: Forecast for the North American Implantable Neurostimulation Device Market ($B) by Application (2025-2031)
• Figure 7.8: Trends and Forecast for the United States Implantable Neurostimulation Device Market ($B) (2019-2031)
• Figure 7.9: Trends and Forecast for the Mexican Implantable Neurostimulation Device Market ($B) (2019-2031)
• Figure 7.10: Trends and Forecast for the Canadian Implantable Neurostimulation Device Market ($B) (2019-2031)
• Figure 8.1: Trends and Forecast for the European Implantable Neurostimulation Device Market (2019-2031)
• Figure 8.2: European Implantable Neurostimulation Device Market by Type in 2019, 2024, and 2031
• Figure 8.3: Trends of the European Implantable Neurostimulation Device Market ($B) by Type (2019-2024)
• Figure 8.4: Forecast for the European Implantable Neurostimulation Device Market ($B) by Type (2025-2031)
• Figure 8.5: European Implantable Neurostimulation Device Market by Application in 2019, 2024, and 2031
• Figure 8.6: Trends of the European Implantable Neurostimulation Device Market ($B) by Application (2019-2024)
• Figure 8.7: Forecast for the European Implantable Neurostimulation Device Market ($B) by Application (2025-2031)
• Figure 8.8: Trends and Forecast for the German Implantable Neurostimulation Device Market ($B) (2019-2031)
• Figure 8.9: Trends and Forecast for the French Implantable Neurostimulation Device Market ($B) (2019-2031)
• Figure 8.10: Trends and Forecast for the Spanish Implantable Neurostimulation Device Market ($B) (2019-2031)
• Figure 8.11: Trends and Forecast for the Italian Implantable Neurostimulation Device Market ($B) (2019-2031)
• Figure 8.12: Trends and Forecast for the United Kingdom Implantable Neurostimulation Device Market ($B) (2019-2031)
• Figure 9.1: Trends and Forecast for the APAC Implantable Neurostimulation Device Market (2019-2031)
• Figure 9.2: APAC Implantable Neurostimulation Device Market by Type in 2019, 2024, and 2031
• Figure 9.3: Trends of the APAC Implantable Neurostimulation Device Market ($B) by Type (2019-2024)
• Figure 9.4: Forecast for the APAC Implantable Neurostimulation Device Market ($B) by Type (2025-2031)
• Figure 9.5: APAC Implantable Neurostimulation Device Market by Application in 2019, 2024, and 2031
• Figure 9.6: Trends of the APAC Implantable Neurostimulation Device Market ($B) by Application (2019-2024)
• Figure 9.7: Forecast for the APAC Implantable Neurostimulation Device Market ($B) by Application (2025-2031)
• Figure 9.8: Trends and Forecast for the Japanese Implantable Neurostimulation Device Market ($B) (2019-2031)
• Figure 9.9: Trends and Forecast for the Indian Implantable Neurostimulation Device Market ($B) (2019-2031)
• Figure 9.10: Trends and Forecast for the Chinese Implantable Neurostimulation Device Market ($B) (2019-2031)
• Figure 9.11: Trends and Forecast for the South Korean Implantable Neurostimulation Device Market ($B) (2019-2031)
• Figure 9.12: Trends and Forecast for the Indonesian Implantable Neurostimulation Device Market ($B) (2019-2031)
• Figure 10.1: Trends and Forecast for the ROW Implantable Neurostimulation Device Market (2019-2031)
• Figure 10.2: ROW Implantable Neurostimulation Device Market by Type in 2019, 2024, and 2031
• Figure 10.3: Trends of the ROW Implantable Neurostimulation Device Market ($B) by Type (2019-2024)
• Figure 10.4: Forecast for the ROW Implantable Neurostimulation Device Market ($B) by Type (2025-2031)
• Figure 10.5: ROW Implantable Neurostimulation Device Market by Application in 2019, 2024, and 2031
• Figure 10.6: Trends of the ROW Implantable Neurostimulation Device Market ($B) by Application (2019-2024)
• Figure 10.7: Forecast for the ROW Implantable Neurostimulation Device Market ($B) by Application (2025-2031)
• Figure 10.8: Trends and Forecast for the Middle Eastern Implantable Neurostimulation Device Market ($B) (2019-2031)
• Figure 10.9: Trends and Forecast for the South American Implantable Neurostimulation Device Market ($B) (2019-2031)
• Figure 10.10: Trends and Forecast for the African Implantable Neurostimulation Device Market ($B) (2019-2031)
• Figure 11.1: Porter's Five Forces Analysis of the Global Implantable Neurostimulation Device Market
• Figure 11.2: Market Share (%) of Top Players in the Global Implantable Neurostimulation Device Market (2024)
• Figure 12.1: Growth Opportunities for the Global Implantable Neurostimulation Device Market by Type
• Figure 12.2: Growth Opportunities for the Global Implantable Neurostimulation Device Market by Application
• Figure 12.3: Growth Opportunities for the Global Implantable Neurostimulation Device Market by Region
• Figure 12.4: Emerging Trends in the Global Implantable Neurostimulation Device Market

List of Tables

• Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Implantable Neurostimulation Device Market by Type and Application
• Table 1.2: Attractiveness Analysis for the Implantable Neurostimulation Device Market by Region
• Table 1.3: Global Implantable Neurostimulation Device Market Parameters and Attributes
• Table 3.1: Trends of the Global Implantable Neurostimulation Device Market (2019-2024)
• Table 3.2: Forecast for the Global Implantable Neurostimulation Device Market (2025-2031)
• Table 4.1: Attractiveness Analysis for the Global Implantable Neurostimulation Device Market by Type
• Table 4.2: Market Size and CAGR of Various Type in the Global Implantable Neurostimulation Device Market (2019-2024)
• Table 4.3: Market Size and CAGR of Various Type in the Global Implantable Neurostimulation Device Market (2025-2031)
• Table 4.4: Trends of Spinal Cord Stimulation (SCS) in the Global Implantable Neurostimulation Device Market (2019-2024)
• Table 4.5: Forecast for Spinal Cord Stimulation (SCS) in the Global Implantable Neurostimulation Device Market (2025-2031)
• Table 4.6: Trends of Gastric Electric Stimulation (GES) in the Global Implantable Neurostimulation Device Market (2019-2024)
• Table 4.7: Forecast for Gastric Electric Stimulation (GES) in the Global Implantable Neurostimulation Device Market (2025-2031)
• Table 4.8: Trends of Deep Brain Stimulation (DBS) in the Global Implantable Neurostimulation Device Market (2019-2024)
• Table 4.9: Forecast for Deep Brain Stimulation (DBS) in the Global Implantable Neurostimulation Device Market (2025-2031)
• Table 4.10: Trends of Sacral Nerve Stimulation (SNS) in the Global Implantable Neurostimulation Device Market (2019-2024)
• Table 4.11: Forecast for Sacral Nerve Stimulation (SNS) in the Global Implantable Neurostimulation Device Market (2025-2031)
• Table 4.12: Trends of Vagus Nerve Stimulation (VNS) in the Global Implantable Neurostimulation Device Market (2019-2024)
• Table 4.13: Forecast for Vagus Nerve Stimulation (VNS) in the Global Implantable Neurostimulation Device Market (2025-2031)
• Table 4.14: Trends of Others in the Global Implantable Neurostimulation Device Market (2019-2024)
• Table 4.15: Forecast for Others in the Global Implantable Neurostimulation Device Market (2025-2031)
• Table 5.1: Attractiveness Analysis for the Global Implantable Neurostimulation Device Market by Application
• Table 5.2: Market Size and CAGR of Various Application in the Global Implantable Neurostimulation Device Market (2019-2024)
• Table 5.3: Market Size and CAGR of Various Application in the Global Implantable Neurostimulation Device Market (2025-2031)
• Table 5.4: Trends of Parkinson's Disease in the Global Implantable Neurostimulation Device Market (2019-2024)
• Table 5.5: Forecast for Parkinson's Disease in the Global Implantable Neurostimulation Device Market (2025-2031)
• Table 5.6: Trends of Epilepsy in the Global Implantable Neurostimulation Device Market (2019-2024)
• Table 5.7: Forecast for Epilepsy in the Global Implantable Neurostimulation Device Market (2025-2031)
• Table 5.8: Trends of Pain Management in the Global Implantable Neurostimulation Device Market (2019-2024)
• Table 5.9: Forecast for Pain Management in the Global Implantable Neurostimulation Device Market (2025-2031)
• Table 5.10: Trends of Others in the Global Implantable Neurostimulation Device Market (2019-2024)
• Table 5.11: Forecast for Others in the Global Implantable Neurostimulation Device Market (2025-2031)
• Table 6.1: Market Size and CAGR of Various Regions in the Global Implantable Neurostimulation Device Market (2019-2024)
• Table 6.2: Market Size and CAGR of Various Regions in the Global Implantable Neurostimulation Device Market (2025-2031)
• Table 7.1: Trends of the North American Implantable Neurostimulation Device Market (2019-2024)
• Table 7.2: Forecast for the North American Implantable Neurostimulation Device Market (2025-2031)
• Table 7.3: Market Size and CAGR of Various Type in the North American Implantable Neurostimulation Device Market (2019-2024)
• Table 7.4: Market Size and CAGR of Various Type in the North American Implantable Neurostimulation Device Market (2025-2031)
• Table 7.5: Market Size and CAGR of Various Application in the North American Implantable Neurostimulation Device Market (2019-2024)
• Table 7.6: Market Size and CAGR of Various Application in the North American Implantable Neurostimulation Device Market (2025-2031)
• Table 7.7: Trends and Forecast for the United States Implantable Neurostimulation Device Market (2019-2031)
• Table 7.8: Trends and Forecast for the Mexican Implantable Neurostimulation Device Market (2019-2031)
• Table 7.9: Trends and Forecast for the Canadian Implantable Neurostimulation Device Market (2019-2031)
• Table 8.1: Trends of the European Implantable Neurostimulation Device Market (2019-2024)
• Table 8.2: Forecast for the European Implantable Neurostimulation Device Market (2025-2031)
• Table 8.3: Market Size and CAGR of Various Type in the European Implantable Neurostimulation Device Market (2019-2024)
• Table 8.4: Market Size and CAGR of Various Type in the European Implantable Neurostimulation Device Market (2025-2031)
• Table 8.5: Market Size and CAGR of Various Application in the European Implantable Neurostimulation Device Market (2019-2024)
• Table 8.6: Market Size and CAGR of Various Application in the European Implantable Neurostimulation Device Market (2025-2031)
• Table 8.7: Trends and Forecast for the German Implantable Neurostimulation Device Market (2019-2031)
• Table 8.8: Trends and Forecast for the French Implantable Neurostimulation Device Market (2019-2031)
• Table 8.9: Trends and Forecast for the Spanish Implantable Neurostimulation Device Market (2019-2031)
• Table 8.10: Trends and Forecast for the Italian Implantable Neurostimulation Device Market (2019-2031)
• Table 8.11: Trends and Forecast for the United Kingdom Implantable Neurostimulation Device Market (2019-2031)
• Table 9.1: Trends of the APAC Implantable Neurostimulation Device Market (2019-2024)
• Table 9.2: Forecast for the APAC Implantable Neurostimulation Device Market (2025-2031)
• Table 9.3: Market Size and CAGR of Various Type in the APAC Implantable Neurostimulation Device Market (2019-2024)
• Table 9.4: Market Size and CAGR of Various Type in the APAC Implantable Neurostimulation Device Market (2025-2031)
• Table 9.5: Market Size and CAGR of Various Application in the APAC Implantable Neurostimulation Device Market (2019-2024)
• Table 9.6: Market Size and CAGR of Various Application in the APAC Implantable Neurostimulation Device Market (2025-2031)
• Table 9.7: Trends and Forecast for the Japanese Implantable Neurostimulation Device Market (2019-2031)
• Table 9.8: Trends and Forecast for the Indian Implantable Neurostimulation Device Market (2019-2031)
• Table 9.9: Trends and Forecast for the Chinese Implantable Neurostimulation Device Market (2019-2031)
• Table 9.10: Trends and Forecast for the South Korean Implantable Neurostimulation Device Market (2019-2031)
• Table 9.11: Trends and Forecast for the Indonesian Implantable Neurostimulation Device Market (2019-2031)
• Table 10.1: Trends of the ROW Implantable Neurostimulation Device Market (2019-2024)
• Table 10.2: Forecast for the ROW Implantable Neurostimulation Device Market (2025-2031)
• Table 10.3: Market Size and CAGR of Various Type in the ROW Implantable Neurostimulation Device Market (2019-2024)
• Table 10.4: Market Size and CAGR of Various Type in the ROW Implantable Neurostimulation Device Market (2025-2031)
• Table 10.5: Market Size and CAGR of Various Application in the ROW Implantable Neurostimulation Device Market (2019-2024)
• Table 10.6: Market Size and CAGR of Various Application in the ROW Implantable Neurostimulation Device Market (2025-2031)
• Table 10.7: Trends and Forecast for the Middle Eastern Implantable Neurostimulation Device Market (2019-2031)
• Table 10.8: Trends and Forecast for the South American Implantable Neurostimulation Device Market (2019-2031)
• Table 10.9: Trends and Forecast for the African Implantable Neurostimulation Device Market (2019-2031)
• Table 11.1: Product Mapping of Implantable Neurostimulation Device Suppliers Based on Segments
• Table 11.2: Operational Integration of Implantable Neurostimulation Device Manufacturers
• Table 11.3: Rankings of Suppliers Based on Implantable Neurostimulation Device Revenue
• Table 12.1: New Product Launches by Major Implantable Neurostimulation Device Producers (2019-2024)
• Table 12.2: Certification Acquired by Major Competitor in the Global Implantable Neurostimulation Device Market

The future of the global implantable neurostimulation device market looks promising with opportunities in the Parkinson's disease, epilepsy, and pain management markets. The global implantable neurostimulation device market is expected to grow with a CAGR of 11.8% from 2025 to 2031. The major drivers for this market are the rising demand for minimally invasive treatments for neurological disorders and the increasing adoption of neurostimulation therapies for pain management & rehabilitation.

• Lucintel forecasts that, within the type category, gastric electric stimulation is expected to witness the highest growth over the forecast period.
• Within the application category, Parkinson's disease is expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Implantable Neurostimulation Device Market

The global implantable neurostimulation device market is undergoing a transformative period, driven by technological advancements, expanding clinical applications, and increasing patient demand for minimally invasive and personalized therapies. These devices, which deliver targeted electrical stimulation to specific areas of the nervous system, are becoming increasingly sophisticated and versatile. Manufacturers are focusing on developing innovative solutions that improve patient outcomes, expand treatment options, and enhance the overall efficiency of neurostimulation therapies. This dynamic landscape is shaping the future of implantable neurostimulation.

• Miniaturization and Wireless Technology: Neurostimulation devices are becoming smaller and more discreet, improving patient comfort and reducing the invasiveness of implantation procedures. Wireless connectivity allows for easier programming, remote monitoring, and data collection, enhancing patient convenience and physician control. This trend is driven by patient preference for less visible devices and the increasing availability of sophisticated microelectronics. Smaller devices can be implanted with minimally invasive procedures, reducing recovery time and the risk of complications. Wireless technology enables real-time data transmission, allowing physicians to adjust stimulation parameters remotely and optimize treatment.
• Personalized Therapy and Closed-Loop Systems: The focus is shifting towards personalized therapy, with devices that can adapt to individual patient needs and provide targeted stimulation. Closed-loop systems, which automatically adjust stimulation based on real-time physiological feedback, are gaining traction. This trend is fueled by the growing understanding of individual variability in neurological conditions and the need for customized treatment approaches. Personalized therapy allows for fine-tuning stimulation parameters to maximize therapeutic benefits and minimize side effects. Closed-loop systems can dynamically adjust stimulation based on changes in patient activity or symptoms, providing more effective and consistent therapy.
• Expanding Applications Beyond Pain: Research is exploring the use of implantable neurostimulation for a wider range of conditions beyond chronic pain, including epilepsy, Parkinson's disease, Alzheimer's disease, and even mental health disorders. This expansion is driven by the growing understanding of the nervous system and the potential of neurostimulation to modulate various neurological pathways. Expanding applications opens up new market opportunities for manufacturers and offers potential treatment options for patients with conditions that are currently difficult to manage. This diversification is driving innovation and attracting investment in research and development.
• Integration with Digital Health Platforms: Implantable neurostimulation systems are increasingly being integrated with digital health platforms, allowing for remote monitoring, data collection, and patient engagement. This integration enables physicians to track patient progress, identify trends, and personalize treatment plans more effectively. This trend is driven by the increasing adoption of digital health technologies and the need for seamless data exchange between patients and healthcare providers. Integration with digital health platforms empowers patients to take a more active role in their care and facilitates healthcare professionals' remote management.
• Focus on Neuromodulation Mechanisms: A deeper understanding of the mechanisms of neuromodulation is driving the development of more targeted and effective neurostimulation therapies. Researchers are investigating how electrical stimulation affects neural circuits and how to optimize stimulation parameters to achieve desired therapeutic effects. This focus on neuromodulation mechanisms is leading to the development of more sophisticated stimulation protocols and device designs. A better understanding of how neurostimulation works allows for the development of more precise and effective therapies.

These emerging trends are reshaping the global implantable neurostimulation device market by driving innovation, expanding treatment options, and improving patient outcomes. The market is moving towards more personalized, less invasive, and more integrated solutions, ultimately leading to better quality of life for patients with neurological disorders.

Recent Developments in the Implantable Neurostimulation Device Market

The global implantable neurostimulation device market is experiencing rapid advancements, driven by technological innovations, expanding clinical applications, and increasing patient demand for minimally invasive and personalized therapies. These devices offer targeted treatment for various neurological conditions, including chronic pain, Parkinson's disease, epilepsy, and movement disorders. Recent developments focus on improved device technology, expanded applications, and greater integration with digital health platforms. Manufacturers are investing in research and development to enhance efficacy, expand treatment options, and improve patient outcomes.

• Advanced Device Technology: Advancements in microelectronics, battery technology, and biomaterials are leading to smaller, more powerful, and longer-lasting implantable neurostimulation devices. This includes improvements in electrode design for more precise stimulation, enhanced wireless communication capabilities, and the development of fully implantable and rechargeable systems. These technological advancements enable more targeted and efficient stimulation, potentially improving therapeutic benefits and reducing side effects. Smaller devices can be implanted through less invasive procedures, leading to faster recovery times and reduced risk of complications.
• Expanding Clinical Applications: Research is exploring the use of implantable neurostimulation for a broader range of conditions beyond traditional pain management, including Alzheimer's disease, depression, traumatic brain injury, and even autoimmune disorders. This expansion is driven by a deeper understanding of the nervous system and the potential of neurostimulation to modulate neural pathways involved in various disorders. Expanding applications opens up new market opportunities and offers potential treatment solutions for patients with conditions that are currently challenging to manage. This diversification drives further research and development in the field.
• Personalized Therapy and Adaptive Stimulation: The trend towards personalized medicine is influencing the development of neurostimulation systems that can be tailored to individual patient needs. This includes features like adaptive stimulation algorithms that adjust stimulation parameters based on real-time physiological feedback, as well as remote monitoring and programming capabilities. Personalized therapy aims to optimize treatment outcomes by taking into account individual variability in symptoms and response to stimulation. This approach can lead to more effective therapy and minimize side effects.
• Integration with Digital Health Platforms: Implantable neurostimulation systems are increasingly being integrated with digital health platforms, allowing for remote patient monitoring, data collection, and telehealth consultations. This integration enables physicians to track patient progress, identify trends, and adjust treatment plans remotely. Integrating digital health platforms improves patient engagement and empowers them to take a more active role in their care. It also facilitates healthcare professionals' remote management, improving access to care, particularly for patients in remote areas.
• Focus on Closed-Loop Systems: Closed-loop neurostimulation systems, which automatically adjust stimulation parameters based on real-time physiological feedback, are gaining traction. These systems can dynamically adjust stimulation based on changes in patient activity or symptoms, providing more effective and consistent therapy. Closed-loop systems have the potential to significantly improve treatment outcomes by delivering stimulation only when needed and adapting to individual patient needs in real-time. This technology is a significant advancement in personalized neurostimulation.

These developments transform the global implantable neurostimulation device market, leading to more advanced, personalized, and accessible therapies. The market is moving towards less invasive procedures, expanded applications, and greater integration with digital health platforms, ultimately improving patient outcomes and quality of life.

Strategic Growth Opportunities in the Implantable Neurostimulation Device Market

The global implantable neurostimulation device market is experiencing robust growth, driven by an aging population, rising prevalence of chronic neurological disorders, and advancements in neurostimulation technology. Beyond established applications like chronic pain and movement disorders, several key growth opportunities are emerging across various medical fields. These opportunities are fueled by increasing clinical evidence, expanding research, and a growing understanding of the nervous system's role in various conditions. Manufacturers are strategically focusing on these areas to expand their market reach and improve patient outcomes.

• Chronic Pain Management: While already a significant market, chronic pain management continues to offer growth opportunities. This includes expanding access to neurostimulation therapies for patients with various chronic pain conditions, improving device efficacy through advanced stimulation algorithms and personalized therapy, and addressing unmet needs in specific pain categories like neuropathic pain and complex regional pain syndrome. Improved patient selection criteria and a better understanding of long-term outcomes also contribute to market growth. Addressing the chronic pain market represents a substantial opportunity due to the large patient population and the limitations of traditional pain management approaches.
• Epilepsy: Implantable neurostimulation is a valuable treatment option for patients with drug-resistant epilepsy. Growth opportunities exist in developing more targeted stimulation protocols, improving seizure detection algorithms, and personalizing therapy based on individual patient needs. Research is also exploring the use of neurostimulation for different types of epilepsy syndromes. The large number of patients with drug-resistant epilepsy and the potential for significant improvement in quality of life make this a substantial market opportunity.
• Parkinson's Disease: Deep brain stimulation (DBS) is a well-established treatment for Parkinson's disease, but growth opportunities remain. This includes refining DBS techniques for better symptom control, developing less invasive implantation procedures, and expanding access to DBS therapy for a wider range of patients. Ongoing research is also exploring the potential of DBS for other movement disorders beyond Parkinson's disease. The increasing prevalence of Parkinson's disease and the proven efficacy of DBS contribute to market growth.
• Urinary and Fecal Incontinence: Sacral nerve stimulation is an effective treatment for urinary and fecal incontinence, but growth opportunities exist in raising patient awareness of this therapy, improving device technology for more targeted stimulation, and exploring the use of neurostimulation for other bladder and bowel disorders. The high prevalence of incontinence and the availability of a proven neurostimulation therapy create a significant market opportunity.
• Alzheimer's Disease and Dementia: Research is exploring the potential of neurostimulation to treat Alzheimer's disease and other forms of dementia. While still in the early stages, this application holds significant promise for slowing disease progression and improving cognitive function. The large and growing population of individuals affected by dementia makes this a potentially substantial market opportunity, though further research is needed to establish efficacy.

These growth opportunities are significantly impacting the global implantable neurostimulation device market by driving innovation, expanding treatment options, and improving patient access to advanced therapies. The market is moving towards more personalized, less invasive, and more effective solutions across a range of neurological conditions, ultimately improving patient outcomes and quality of life.

Implantable Neurostimulation Device Market Driver and Challenges

The global implantable neurostimulation device market is a dynamic sector characterized by a complex interplay of technological advancements, evolving patient needs, economic pressures, and regulatory considerations. These factors are shaping the market's trajectory, driving innovation while also presenting significant hurdles. Understanding these drivers and challenges is crucial for stakeholders to effectively navigate this evolving market and capitalize on emerging opportunities. Success in this space requires a delicate balance of innovation, clinical efficacy, cost-effectiveness, and regulatory compliance.

The factors responsible for driving the implantable neurostimulation device market include:

1. Aging Population and Rising Prevalence of Neurological Disorders: The global population is aging, leading to a significant increase in the prevalence of chronic neurological conditions like Parkinson's disease, epilepsy, chronic pain, and incontinence. This demographic shift is a major driver of the neurostimulation device market, as these devices offer effective treatment options for many of these conditions. The increasing demand for advanced neurological care fuels market growth.

2. Technological Advancements: Continuous advancements in microelectronics, battery technology, biomaterials, and stimulation algorithms are leading to smaller, more sophisticated, and longer-lasting devices. These advancements include improved electrode design, enhanced wireless communication, and the development of closed-loop systems, all of which enhance device efficacy and patient comfort. Technological progress is a key driver of market expansion.

3. Expanding Clinical Applications: Research is exploring the use of implantable neurostimulation for a broader range of conditions beyond traditional pain management and movement disorders, including Alzheimer's disease, depression, traumatic brain injury, and even autoimmune disorders. These expanding applications are creating new market opportunities and driving further research and development in the field. The potential to treat a wider range of conditions fuels market growth.

4. Growing Patient Awareness and Acceptance: Increased awareness of implantable neurostimulation as a viable treatment option, coupled with positive clinical outcomes, is driving patient acceptance. This growing awareness is facilitated by educational initiatives, physician recommendations, and positive patient testimonials. Greater patient acceptance contributes to market growth.

5. Increasing Healthcare Expenditure: Rising healthcare expenditure in many countries is providing greater access to advanced medical technologies, including implantable neurostimulation systems. This increased spending allows more patients to afford these therapies and contributes to market expansion. Increased healthcare spending supports market growth.

Challenges in the implantable neurostimulation device market are:

1. High Cost of Devices and Procedures: Implantable neurostimulation systems and the associated implantation procedures can be expensive, limiting patient access, particularly in developing countries. Cost remains a significant barrier to wider adoption despite the long-term benefits of improved quality of life. High cost is a major market challenge.

2. Reimbursement Policies and Regulatory Hurdles: Complex reimbursement policies and regulatory approval processes can create challenges for manufacturers and slow down market access for new devices. Navigating these regulatory and reimbursement landscapes requires significant resources and can delay product launches. Regulatory hurdles pose a challenge to market growth.

3. Need for Skilled Professionals: The implantation and programming of implantable neurostimulation systems require specialized training and expertise. A shortage of skilled professionals, particularly in certain regions, can limit patient access to these therapies. The availability of trained professionals is crucial for market development.

In summary, the implantable neurostimulation device market is driven by an aging population, technological advancements, expanding applications, and increasing patient awareness. However, challenges related to cost, reimbursement, regulation, and the availability of skilled professionals need to be addressed to fully realize the market's potential. Overcoming these challenges will be crucial for the continued growth and expansion of neurostimulation therapies.

List of Implantable Neurostimulation Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, implantable neurostimulation device companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the implantable neurostimulation device companies profiled in this report include-

• Medtronic
• Boston Scientific
• Abbott
• LivaNova
• Nevro
• Ruishenan Medical
• Beijing Pins
• Sceneray
• Inspire Medical Systems
• Nurotron

Implantable Neurostimulation Device Market by Segment

The study includes a forecast for the global implantable neurostimulation device market by type, application, and region.

Implantable Neurostimulation Device Market by Type [Value from 2019 to 2031]:

• Spinal Cord Stimulation (SCS)
• Gastric Electric Stimulation (GES)
• Deep Brain Stimulation (DBS)
• Sacral Nerve Stimulation (SNS)
• Vagus Nerve Stimulation (VNS)
• Others

Implantable Neurostimulation Device Market by Application [Value from 2019 to 2031]:

• Parkinson's Disease
• Epilepsy
• Pain Management
• Others

Implantable Neurostimulation Device Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Implantable Neurostimulation Device Market

The global implantable neurostimulation device market is experiencing significant growth, driven by an aging population, rising prevalence of chronic pain and neurological disorders, and advancements in neurostimulation technology. These devices offer targeted therapy for various conditions, including chronic pain, Parkinson's disease, epilepsy, and bladder control issues. Recent developments focus on miniaturization, improved battery life, advanced stimulation algorithms, and expanding applications. Manufacturers are also investing in research to explore new indications and improve patient outcomes.

• United States: The US market is highly innovative, with major players investing in R&D. Recent developments include FDA approvals for new devices with advanced features like closed-loop systems for personalized therapy and smaller, more discreet implantable pulse generators (IPGs). There's also a growing trend towards integrating neurostimulation devices with digital health platforms for remote monitoring and data analysis.
• China: The Chinese market is witnessing rapid growth due to increasing healthcare expenditure and a large patient population. Domestic manufacturers are focusing on developing cost-effective devices to cater to the growing demand. Recent developments include the introduction of new spinal cord stimulation (SCS) systems and deep brain stimulation (DBS) systems with improved efficacy and safety profiles. The government is also promoting the adoption of advanced medical technologies.
• Germany: Germany has a well-established healthcare system and a strong focus on research and development. The market is characterized by the presence of major international players and a growing demand for minimally invasive procedures. Recent developments include the introduction of new devices with improved battery life and enhanced pain relief capabilities. There is also a growing interest in the use of neurostimulation for the treatment of conditions like migraines and epilepsy.
• India: The Indian market is expected to witness significant growth due to increasing awareness about neurostimulation and rising disposable incomes. However, the market is still at a nascent stage, with a limited number of specialized clinics and a lack of skilled professionals. Recent developments include the entry of new players offering affordable devices and initiatives by the government to promote medical tourism. There is also a growing focus on training and education programs for healthcare professionals in neurostimulation techniques.
• Japan: The Japanese market is characterized by a high prevalence of chronic pain and neurological disorders and a growing geriatric population. The government is actively promoting the adoption of advanced medical technologies to improve patient outcomes. Recent developments include the development of new devices with smaller footprints and improved patient comfort. There is also a growing emphasis on the use of neurostimulation for the treatment of conditions like Parkinson's disease and chronic pain.

Features of the Global Implantable Neurostimulation Device Market

• Market Size Estimates: Implantable neurostimulation device market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Implantable neurostimulation device market size by type, application, and region in terms of value ($B).
• Regional Analysis: Implantable neurostimulation device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the implantable neurostimulation device market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the implantable neurostimulation device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the implantable neurostimulation device market by type (spinal cord stimulation (SCS), gastric electric stimulation (GES), deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS), and others), application (parkinson's disease, epilepsy, pain management, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Implantable Neurostimulation Device Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Spinal Cord Stimulation (SCS): Trends and Forecast (2019-2031)
• 4.4 Gastric Electric Stimulation (GES): Trends and Forecast (2019-2031)
• 4.5 Deep Brain Stimulation (DBS): Trends and Forecast (2019-2031)
• 4.6 Sacral Nerve Stimulation (SNS): Trends and Forecast (2019-2031)
• 4.7 Vagus Nerve Stimulation (VNS): Trends and Forecast (2019-2031)
• 4.8 Others: Trends and Forecast (2019-2031)

5. Global Implantable Neurostimulation Device Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Parkinson's Disease: Trends and Forecast (2019-2031)
• 5.4 Epilepsy: Trends and Forecast (2019-2031)
• 5.5 Pain Management: Trends and Forecast (2019-2031)
• 5.6 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Implantable Neurostimulation Device Market by Region

7. North American Implantable Neurostimulation Device Market

• 7.1 Overview
• 7.2 North American Implantable Neurostimulation Device Market by Type
• 7.3 North American Implantable Neurostimulation Device Market by Application
• 7.4 United States Implantable Neurostimulation Device Market
• 7.5 Mexican Implantable Neurostimulation Device Market
• 7.6 Canadian Implantable Neurostimulation Device Market

8. European Implantable Neurostimulation Device Market

• 8.1 Overview
• 8.2 European Implantable Neurostimulation Device Market by Type
• 8.3 European Implantable Neurostimulation Device Market by Application
• 8.4 German Implantable Neurostimulation Device Market
• 8.5 French Implantable Neurostimulation Device Market
• 8.6 Spanish Implantable Neurostimulation Device Market
• 8.7 Italian Implantable Neurostimulation Device Market
• 8.8 United Kingdom Implantable Neurostimulation Device Market

9. APAC Implantable Neurostimulation Device Market

• 9.1 Overview
• 9.2 APAC Implantable Neurostimulation Device Market by Type
• 9.3 APAC Implantable Neurostimulation Device Market by Application
• 9.4 Japanese Implantable Neurostimulation Device Market
• 9.5 Indian Implantable Neurostimulation Device Market
• 9.6 Chinese Implantable Neurostimulation Device Market
• 9.7 South Korean Implantable Neurostimulation Device Market
• 9.8 Indonesian Implantable Neurostimulation Device Market

10. ROW Implantable Neurostimulation Device Market

• 10.1 Overview
• 10.2 ROW Implantable Neurostimulation Device Market by Type
• 10.3 ROW Implantable Neurostimulation Device Market by Application
• 10.4 Middle Eastern Implantable Neurostimulation Device Market
• 10.5 South American Implantable Neurostimulation Device Market
• 10.6 African Implantable Neurostimulation Device Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Implantable Neurostimulation Device Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Medtronic
  • Company Overview
  • Implantable Neurostimulation Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Boston Scientific
  • Company Overview
  • Implantable Neurostimulation Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Abbott
  • Company Overview
  • Implantable Neurostimulation Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 LivaNova
  • Company Overview
  • Implantable Neurostimulation Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Nevro
  • Company Overview
  • Implantable Neurostimulation Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Ruishenan Medical
  • Company Overview
  • Implantable Neurostimulation Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Beijing Pins
  • Company Overview
  • Implantable Neurostimulation Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 Sceneray
  • Company Overview
  • Implantable Neurostimulation Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 Inspire Medical Systems
  • Company Overview
  • Implantable Neurostimulation Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.11 Nurotron
  • Company Overview
  • Implantable Neurostimulation Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us